Repare Therapeutics (NASDAQ:RPTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They currently have a $10.00 target price on the stock. HC Wainwright’s price target indicates a potential upside of 59.24% from the company’s […]
Repare Therapeutics (NASDAQ:RPTX – Free Report) had its price objective decreased by HC Wainwright from $25.00 to $10.00 in a research report report published on Wednesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Repare Therapeutics’ Q2 2024 earnings at ($0.96) EPS, Q3 2024 earnings […]
The law firm of Kirby McInerney LLP is investigating potential claims against Repare Therapeutics Inc. . The investigation concerns whether Repare and/or certain of its officers have violated the.